Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.17 Analyst target: $17.00 Upside: 1352.99%
Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United States. The company is headquartered in Rehovot, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.